期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Research in Chinese Medicine. 2023; 3: (2) ; 44-46 ; DOI: 10.12208/j.ircm.20230016.

Effect of traditional Chinese medicine on advanced non-small cell lung cancer of spleen deficiency and dampness resistance type
中医治疗脾虚湿阻型晚期非小细胞肺癌的效果

作者: 史海霞 *

易县中医医院 河北保定

*通讯作者: 史海霞,单位:易县中医医院 河北保定;

发布时间: 2023-04-23 总浏览量: 268

摘要

目的 分析脾虚湿阻型晚期非小细胞肺癌治疗中应用中医方法的效果。方法 本次研究的脾虚湿阻型晚期非小细胞肺癌患者为44例,患者均选自于2020年11月-2021年11月,应用不同治疗方法分为22例对照组(常规放疗、化疗和靶向治疗)和22例研究组(对照组基础上增加中医药治疗),比较组间治疗效果和预后情况。结果 研究组和对照组的治疗效果分别为90.90%、54.54%;研究组患者的预后情况较对照组好,组间对比差异为P<0.05。结论 使用中医方法治疗脾虚湿阻型晚期非小细胞肺癌治患者能获得良好效果,能促使患者预后。

关键词: 中医治疗;脾虚湿阻型;非小细胞肺癌

Abstract

Objective To analyze the effect of traditional Chinese medicine in the treatment of advanced non-small cell lung cancer of spleen deficiency and dampness resistance type.
Methods 44 patients with advanced non-small cell lung cancer of spleen deficiency damp-resistance type in this study were selected from November 2020 to November 2021. They were divided into 22 control groups (conventional radiotherapy, chemotherapy and targeted treatment) and 22 study groups (control group plus Chinese medicine treatment) by different treatment methods, and the treatment effect and prognosis between the groups were compared.
Results The therapeutic effects of the study group and the control group were 90.90% and 54.54% respectively; The prognosis of patients in the study group was better than that in the control group, and the difference between the two groups was P<0.05.
Conclusion   Using traditional Chinese medicine to treat advanced non-small cell lung cancer patients with spleen deficiency and dampness resistance can achieve good results and promote the prognosis of patients.

Key words: TCM treatment; Spleen deficiency and dampness resistance type; Non-small cell lung cancer

参考文献 References

[1] 陈宗慧. 非小细胞肺癌病理分型、TNM分期与中医证型的相关性分析[J]. 中国民族民间医药, 2022, 31(15): 88-91.

[2] 蒙家泉,焦丽静,许玲. 中医药联合治疗延缓非小细胞肺癌对EGFR-TKIs耐药的临床研究近况[J]. 现代中西医结合杂志,2022,31(10):1445-1449. 

[3] 蔡江河,陈茂华,苏元新,等. 脾虚湿阻型晚期非小细胞肺癌中医治疗效果分析[J]. 医药前沿,2019,9(26):210-211.

[4] 李晓芳,刘标,国风,等. 益肺消积颗粒联合表皮生长因子受体-酪氨酸激酶抑制剂治疗不同证型晚期非小细胞肺癌疗效观察[J]. 现代中西医结合杂志, 2020, 29(36): 3996-4001.

[5] 胡玉锋,黄松华. 化癥扶正汤联合TP方案治疗非小细胞肺癌疗效及对患者中医证候、免疫功能的影响[J]. 医学理论与实践, 2023,36(4):602-604. 

[6] 肖真真,朱燕娟,刘译鸿,等. 非小细胞肺癌中医辨证分型与肿瘤免疫微环境的关系[J]. 中医肿瘤学杂志, 2022, 4(4): 14-20. 

[7] 芦希艳,姚家久,赵宁侠. 中医辨证辅助化疗治疗非小细胞肺癌的临床疗效及对患者免疫功能和预后的影响[J]. 癌症进展,2022,20(8):797-799,804. 

[8] 李娜,田劭丹,董青,等. 陈信义教授运用中医药分阶段治疗非小细胞肺癌临床经验[J]. 世界中西医结合杂志, 2022, 17(12): 2397-2400.

引用本文

史海霞, 中医治疗脾虚湿阻型晚期非小细胞肺癌的效果[J]. 国际中医药研究, 2023; 3: (2) : 44-46.